Efficacy of convalescent plasma therapy in improving survival in non-immunized COVID-19 patients
Abstract Purpose Convalescent plasma (CP), obtained from individuals who have recovered from COVID-19, has been widely explored as a potential therapeutic option, particularly in the absence of vaccines and monoclonal antibody treatments. This study aimed to evaluate the effectiveness of CP therapy...
Saved in:
| Main Authors: | Tania Portella Costa, Dayanne Mozaner Bordin, Mateus Nóbrega Aoki, Lucas Blanes |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Virology Journal |
| Online Access: | https://doi.org/10.1186/s12985-025-02778-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of convalescent plasma for treatment of COVID-19 in Uganda
by: Trishul Siddharthan, et al.
Published: (2021-01-01) -
Efficacy of COVID-19 Convalescent Plasma Based on Antibody Concentration
by: Wesley V Cain, et al.
Published: (2022-01-01) -
Efficacy of COVID convalescent plasma therapy in hospitalized moderate coronavirus disease 2019 patients
by: Cosphiadi Irawan, et al.
Published: (2023-01-01) -
Features of immune status in COVID-19 convalescents
by: Alina S. Shkaberda, et al.
Published: (2022-06-01) -
Impact of variable titer COVID-19 convalescent plasma and recipient SARS-CoV2-specific humoral immunity on survival in hospitalized patients.
by: Carlo J Iasella, et al.
Published: (2024-01-01)